Perspective Therapeutics presented new Phase 1/2a trial data showing that bamzireotide (VMT-α-NET) achieved durable disease control and promising tumor responses in patients with advanced neuroendocrine tumors expressing SSTR2. Among 57 patients with gastroenteropancreatic NETs, progression-free survival was 75% at 18 months, with disease control rates up to 100% in some cohorts. The treatment was well-tolerated with no dose-limiting toxicities reported. The company plans to discuss these findings with regulators and aims to start Phase 3 trials in 2027 following an end-of-Phase 2 meeting in early 2027.
Perspective Therapeutics' trial results provide context alongside Pluang's health sector data. Of 150 priced health-sector US stocks on Pluang, 18 rose and 132 fell today. Notable movers include TWST at USD 120.75 down 15.31%, CYTK at USD 54.00 up 100% buy activity, and DNA at USD 10.00 with 100% buy activity, as of Nov 06, 2026 07:51 WIB.
Ademi LLP is investigating Strategic Education for potential securities fraud related to inaccurate statements about its financials and business operations, particularly in Australia. This probe follows a more than 20% decline in the company's stock ...
Corporate Insight released research identifying top financial firms leading in customer-facing AI tools, including virtual assistants and AI-powered fintech platforms. Fidelity and Voya lead in retirement plan virtual assistants, while Lively excels ...
Strawberry Fields REIT announced a cash dividend of $0.17 per common share for the fourth quarter of 2026. The dividend will be paid on December 30, 2026, to shareholders recorded by December 16, 2026. The company specializes in owning and leasing he...
Stacks (STX) surged 9.99% to $0.360, leading gains among the 90 largest cryptocurrencies as 77 advanced over 24 hours. Other notable winners included Injective (INJ) up 9.37%, Pearl (PEARL) up 8.29%, Render (RENDER) up 7.26%, and PancakeSwap (CAKE) u...
Ethereum's EIP-8297, known as the Partitioned Binary Tree (PBT), passed a key mainnet shadowfork test, marking progress toward a full deployment planned for Q4 2026. The upgrade restructures Ethereum's state data into a simpler binary tree format, ai...
